Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsStem CellsGraft vs Host DiseaseTransplantation, AutologousHematopoietic Stem Cell TransplantationHematopoietic Stem CellsWhole-Body IrradiationBone and BonesTransplantation ConditioningStem Cell TransplantationAnemia, AplasticLeukemiaTransplantation ChimeraLiver TransplantationGraft SurvivalTissue DonorsBusulfanBone Marrow PurgingHistocompatibility TestingHistocompatibilityHematopoiesisCyclophosphamideTransplantation, IsogeneicTh2 CellsMice, Inbred C57BLBone Marrow DiseasesTh1 CellsCell DifferentiationKidney TransplantationRecurrenceCombined Modality TherapyRadiation ChimeraLeukemia, Myelogenous, Chronic, BCR-ABL PositiveEmbryonic Stem CellsLeukemia, Myeloid, AcuteHematologic NeoplasmsTime FactorsTreatment OutcomeBone Marrow ExaminationRemission InductionImmunosuppressive AgentsAdult Stem CellsGraft RejectionPrecursor Cell Lymphoblastic Leukemia-LymphomaHepatic Veno-Occlusive DiseaseBone RemodelingColony-Forming Units AssayTransplantation ImmunologyBone Marrow NeoplasmsLeukemia, MyeloidGraft vs Host ReactionMesenchymal Stem Cell TransplantationLymphocyte DepletionImmunosuppressionLymphoma, Non-HodgkinAcute DiseaseChimeraLeukocyte TransfusionHeart TransplantationCells, CulturedT-LymphocytesSevere Combined ImmunodeficiencyMyelodysplastic SyndromesSurvival AnalysisHLA AntigensPluripotent Stem CellsRetrospective StudiesStem Cell NicheFlow CytometryHematologic DiseasesCell LineageMesenchymal Stromal CellsLung TransplantationCyclosporineLymphocyte TransfusionActuarial AnalysisBone DensityAntineoplastic Combined Chemotherapy ProtocolsAntigens, CD34Granulocyte Colony-Stimulating FactorHematopoietic Stem Cell MobilizationNuclear FamilyCarmustineMice, Inbred BALB CGraft vs Tumor EffectCell SeparationPeripheral Blood Stem Cell TransplantationStem Cell FactorGraft vs Leukemia EffectPancytopeniaFollow-Up StudiesOrgan TransplantationSurvival RateCytarabineTh17 CellsSpleenLeukocyte Count